SFL

OSCC Cell Line STR information 20150312 更新版

/ , ,

OSCC Cell Line STR information 20150312 更新版由 sufang 在 一, 03/30/2015 – 08:45 發表 Oral Cancer OSCC Cell Line STR analysis Dear all, 更新oral cancer相關細胞株之STR資訊共有16個細胞株, 其中DOK, FaDu, HOK, HSC-3, KB, OEC-M1, SCC-15, SCC-9, Tu-183(共9株)有送件STR的資訊(詳如附件)須請大家注意的資訊如下:1. HSC-3, 於Dr.郭靜娟’s lab的新HSC-3為真, 請非此來源者把舊的細胞扔了吧! (p.s Dr. 李岳倫於2014年7月及9月分別定的STR結果同新HSC-3, 推測亦為可用細胞株)2. KB, 於Dr.郭靜娟’s lab定STR結果為HeLa細胞, ATCC/JCRB資料庫也證明KB為HeLa. 請勿使用此細胞株!3. SCC-15, Dr.李岳倫’s lab 於2014年9月及10月分別定的STR結果皆與SAS細胞株相符(90.9% match), 使用此細胞株請小心!4. Tu-183, 於Dr.江士昇’s […]

OSCC Cell Line STR information 20150312 更新版 Read More »

大家講過的Paper大全

/ ,

2015/03/24 陳貞佩 Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors 2015/03/10 楊韻涵  NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival 2015/02/10 王思涵 Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration  2015/01/06 小嬿 RFTS-deleted DNMT1

大家講過的Paper大全 Read More »

2015/01/30 國長會議

/ ,

由 sufang 在 五, 03/13/2015 – 08:29 發表 Pre-published 國長會議 長庚 國衛院長庚雙邊會議 2015/01/30 (五) at 林口長庚 王陸海: miR491-3p is responsible for oral cancer metastasis葉大森: bile duct cancer (miRNA 200下降), liver cancer (miRNA 200 上升，which is correlated with EMT)陳鈴津教授介紹 閻紫宸教授另外一個專長是 radio pharmatheutical research (新藥開發 GMP等等)———————–趙盈凱 副教授【胸腔外科】可吸收性生物醫材在食道癌之應用東方人食道癌 是由ABC引起的、西方的食道癌則多由胃食道逆流證實CCRT+Surgert is better therapy than just surgery-Big Database (2400 病人

2015/01/30 國長會議 Read More »

TCGA HNSCC Marker Paper

/ , ,

由 sufang 在 五, 02/27/2015 – 10:08 發表 Oral Cancer HNSCC TCGA Comprehensive genomic characterization of head and neck squamous cell carcinomas (pdf 4292; PubMed Link) The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations. Here we show that human-papillomavirus-associated tumours are dominated by helical

TCGA HNSCC Marker Paper Read More »

寄送SW780 RNA給長庚及行動基因陳華鍵

/ , ,

寄送SW780 RNA給長庚及行動基因陳華鍵由 sufang 在 五, 02/13/2015 – 15:20 發表 Cholangiocarcinoma GeneFusion From: Su­Fang Lin [mailto:sflin1@gmail.com] Sent: Friday, January 30, 2015 2:06 PMTo: angel945@cgmh.org.twSubject: this is Su­Fang’s email Dear Dr. 趙:This is my email. I will prepare ~5­10 micrograms RNAs from SW780 cells for your control. Please let me know to whom and to where should I sent. Thanks! Best, Su­Fang  ————————————– Angel

寄送SW780 RNA給長庚及行動基因陳華鍵 Read More »

Fusion gene detection 2014-Dec 及 TLCN檢體申請

/ , ,

Fusion gene detection 2014-Dec 及 TLCN檢體申請由 sufang 在 三, 01/21/2015 – 11:29 發表 Cholangiocarcinoma cholangiocarcinoma FGFR2 gene fusion Nov 27, 2014 at 2:57 PM To: Su-Fang Lin Dear SF, Only minor suggestions (in red color). Are you going to list the oncogenes screening in your proposal or we can just perform the exam? I am

Fusion gene detection 2014-Dec 及 TLCN檢體申請 Read More »

Collaborative Projects between KMUH and NICR

/ ,

General Fluidigm Access Array + MySeq –YouTube 1: https://www.youtube.com/watch?v=s9HUhuCbbhU –YouTube 2: https://www.youtube.com/watch?v=WXpNjcRwdj8 –AA_Illumina_ug_100-3770 (pdf) –RecoverAll Total Nucleic Acid Isolation Kit for FFPE (pdf)   台大郭頌鑫醫師抽取DNA and RNA from tiny endoscopic biopsy samples使用。 –陳華鍵老師他們新開的公司行動基因,用的是類似方法、只是不同機器(Ion Torrent PGM/Proton) –Archer: Archer™ FusionPlex™ FGFR Panel (USD 495 / 8 rxn) –Life: Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel –與台大合作部分，詳見HPV and p16 in HNSCC. (按我連結)  –ds-cDNA protocal from Yi-Mi and Dan (03/05/2015). (按我下載)

Collaborative Projects between KMUH and NICR Read More »

癌症個人化醫療前瞻論壇 @ 台北喜來登 星月廳 (B2F)

/ ,

20150111_癌症個人化醫療前瞻論壇 @ 台北喜來登 星月廳 (B2F)由 sufang 在 日, 01/11/2015 – 20:41 發表 Pre-published Meeting Oral Cancer Opening remarks: 賴瓊慧教授 (副研發長) 主持人: 王子豪醫師 (國外廠商contact him about STIP1) 閻紫宸教授: 台灣口腔癌病患新穎癒後生物標誌的發現與臨床意義 –Why OSCC: Taiwan has the oral cancer incidence in men worldwide –Oral cavity cancer: incidence, survival and treatment –廖俊達教授is the head of CGH HNSCC group leader (pastic

癌症個人化醫療前瞻論壇 @ 台北喜來登 星月廳 (B2F) Read More »

與IBPR開會小記

/ ,

由 sufang 在 五, 12/05/2014 – 10:12 發表 Pre-published IBPR Meeting 杏國Syncore (DBPR204, DBPR 104) 健亞Genovat (DBPR108, T2DM) 中天(Microbio)   cKIT, IDO1, IDH1, 大分子   COE of New Drug Discovery Success in clinical trials and regulation approval Drug discovery engine Team of excellent investigators Mentor/coaching/networking Triangular relationship (Target, Drug, Disease) PK/PD correlation Biomarkers Translational model

與IBPR開會小記 Read More »

Scroll to Top